Funding will support a randomized Phase 2B study of the novel sonodynamic therapy in patients with newly diagnosed glioblastoma "The complex and diffuse nature of glioblastomas has long hindered ...

A Chanhassen-based medical company has raised $52 million in its quest to treat an aggressive form of brain cancer. Late last week, Alpheus Medical Inc. announced that it closed its Series B funding ...

"The early clinical results are very encouraging for advancing treatment options in patients with newly diagnosed glioblastoma, a disease with few effective therapies," commented Walter Stummer, ...

Chanhassen-based Alpheus Medical has raised $14 million to advance its development of sonodynamic therapy (SDT) to treat large aggressive brain tumors. Founded just a year ago, in 2021, Alpheus ...

The MarketWatch News Department was not involved in the creation of this content. The company has enrolled 10 patients, marking early momentum in evaluating a novel, non-invasive, drug-centered ...

The results from their first-in-human study demonstrated that median overall survival was doubled and progression-free survival improved 3-fold The Company's novel sonodynamic therapy platform ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Alpheus’ therapy centers on ...

The Gores Group, a leading Los Angeles-based private equity firm, today announced that through an affiliate it has completed the acquisition of Alpheus Communications, one of the largest fiber network ...

HOUSTON--(BUSINESS WIRE)--Alpheus Communications, a leading provider of Texas metro-regional fiber and networking solutions, today announced that Matt Milliron has joined the company as senior vice ...

The Gores Group, a leading Los Angeles-based private equity firm, today announced that through an affiliate it has signed an agreement to acquire Alpheus Communications, one of the largest fiber ...